About KV Pharmaceutical Company
KV Pharmaceutical Company is a fully integrated specialty pharmaceutical company that develops, manufactures, markets and acquires technology-distinguished branded and generic/non-branded prescription pharmaceutical products. The Company markets its technology-distinguished products through ETHEX Corporation, a national leader in pharmaceuticals that compete with branded products, and Ther-Rx Corporation, its emerging branded prescription pharmaceutical subsidiary.
For further information about KV Pharmaceutical Company, please visit the Company's corporate website at http://www.kvpharmaceutical.com.
The information in this release may contain various forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995 ("PSLRA") and which may be based on or include assumptions concerning KV's operations, future results and prospects. Such statements may be identified by the use of words like "plans", "expect", "aim", "believe", "projects", "anticipates", "commit", "intend", "estimate", "will", "should", "could" and other expressions that indicate future events and trends.
All statements that address expectations or projections about the
future, including without limitation, statements about the amount and
allocation of cumulative charges and compensation expense, the Company's
filing of its Form 10-K and continued satisfaction of the continued listing
requirements on the New York Stock Exchange, and the Company's strategy for
growth, product development, product launches, regulatory approvals, market
position, acquisitions, revenues, expenditures and other financial results,
|SOURCE KV Pharmaceutical Company|
Copyright©2007 PR Newswire.
All rights reserved